Apparent China Study Failure May Not Spell End For Remdesivir COVID-19 Role

Antiviral‘s Role In Severe Patients Is Bigger Question

 
• By Brian Yang
  
Corona patient
RESULTS FROM REMDESIVIR CHINA STUDY SHOWS NO SIGNIFICANT IMPROVE IN COVID-19 MORTALITY • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia